Search Results - "Bashey, Asad"
-
1
The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantation
Published in Bone marrow transplantation (Basingstoke) (01-01-2020)“…The number of HLA-haploidentical hematopoietic cell transplants continues to increase worldwide due to recent improvements in outcomes, allowing more patients…”
Get full text
Journal Article -
2
Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes
Published in Journal of clinical oncology (10-04-2017)“…Purpose The optimal regimen intensity before allogeneic hematopoietic cell transplantation (HCT) is unknown. We hypothesized that lower treatment-related…”
Get full text
Journal Article -
3
T-Cell–Replete HLA-Haploidentical Hematopoietic Transplantation for Hematologic Malignancies Using Post-Transplantation Cyclophosphamide Results in Outcomes Equivalent to Those of Contemporaneous HLA-Matched Related and Unrelated Donor Transplantation
Published in Journal of clinical oncology (01-04-2013)“…T-cell-replete grafts from haploidentical donors using post-transplantation cyclophosphamide may represent a solution for patients who require allogeneic…”
Get full text
Journal Article -
4
Ipilimumab for Patients with Relapse after Allogeneic Transplantation
Published in The New England journal of medicine (14-07-2016)“…Hematologic cancers that recur after allogeneic hematopoietic stem-cell transplantation are often difficult to treat. A small pilot study suggests that…”
Get full text
Journal Article -
5
Autologous Transplantation, Consolidation, and Maintenance Therapy in Multiple Myeloma: Results of the BMT CTN 0702 Trial
Published in Journal of clinical oncology (01-03-2019)“…Single-cycle melphalan 200 mg/m and autologous hematopoietic cell transplantation (AHCT) followed by lenalidomide (len) maintenance have improved…”
Get full text
Journal Article -
6
PD-1 blockade for relapsed lymphoma post–allogeneic hematopoietic cell transplant: high response rate but frequent GVHD
Published in Blood (13-07-2017)“…Given the limited treatment options for relapsed lymphoma post–allogeneic hematopoietic cell transplantation (post–allo-HCT) and the success of programmed…”
Get full text
Journal Article -
7
The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation
Published in Bone marrow transplantation (Basingstoke) (01-05-2018)“…Haploidentical donors are now increasingly considered for transplantation in the absence of HLA-matched donors or when an urgent transplant is needed…”
Get full text
Journal Article -
8
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
Published in The New England journal of medicine (10-05-2012)“…In patients who had undergone stem-cell transplantation, lenalidomide maintenance therapy improved progression-free and overall survival, though at the expense…”
Get full text
Journal Article -
9
Allogeneic blood or marrow transplantation with haploidentical donor and post-transplantation cyclophosphamide in patients with myelofibrosis: a multicenter study
Published in Leukemia (01-03-2022)“…We report the results from a multicenter retrospective study of 69 adult patients who underwent haploidentical blood or marrow transplantation (haplo-BMT) with…”
Get full text
Journal Article -
10
A multicenter phase 1 study of nivolumab for relapsed hematologic malignancies after allogeneic transplantation
Published in Blood (11-06-2020)“…Programmed cell death-1 (PD-1)/programmed death ligand-1 blockade may potentially augment graft-vs-tumor effects following allogeneic hematopoietic cell…”
Get full text
Journal Article -
11
Nonmyeloablative Alternative Donor Transplantation for Hodgkin and Non-Hodgkin Lymphoma: From the LWP-EBMT, Eurocord, and CIBMTR
Published in Journal of clinical oncology (10-05-2020)“…To compare the outcomes of patients with Hodgkin or non-Hodgkin lymphoma undergoing nonmyeloablative haploidentical or unrelated cord blood (UCB) hematopoietic…”
Get full text
Journal Article -
12
Fevers post infusion of T-cell replete hla mismatched haploidentical hematopoietic stem cells with post-transplant cyclophosphamide: risk factors and impact on transplant outcomes
Published in Bone marrow transplantation (Basingstoke) (01-11-2019)“…Fever is a common early complication after infusion of stem cells in patients undergoing T-replete HLA haploidentical transplantation using post-transplant…”
Get full text
Journal Article -
13
Haploidentical donor hematopoietic cell transplantation for myelodysplastic/myeloproliferative overlap neoplasms: results from a North American collaboration
Published in Haematologica (Roma) (01-12-2023)“…Haploidentical donors offer a potentially readily available donor, especially for non-White patients, for hematopoietic cell transplantation (HCT). In this…”
Get full text
Journal Article -
14
Myeloablative versus Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation in Acute Myelogenous Leukemia and Myelodysplastic Syndromes—Long-Term Follow-Up of the BMT CTN 0901 Clinical Trial
Published in Transplantation and cellular therapy (01-06-2021)“…•There was a higher rate of treatment-related mortality with myeloablative conditioning, but this was offset by a much higher rate of relapse with…”
Get full text
Journal Article -
15
Long term survival among patients who are disease free at 1-year post allogeneic hematopoietic cell transplantation: a single center analysis of 389 consecutive patients
Published in Bone marrow transplantation (Basingstoke) (01-05-2018)“…Allogeneic hematopoietic cell transplantation (HCT) is associated with significant morbidity and mortality especially in the first year after HCT. In this…”
Get full text
Journal Article -
16
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
Published in The New England journal of medicine (10-05-2012)Get full text
Journal Article -
17
Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamide
Published in Blood advances (13-02-2018)“…We studied the association between non-HLA donor characteristics (age, sex, donor-recipient relationship, blood group [ABO] match, and cytomegalovirus [CMV]…”
Get full text
Journal Article -
18
The effect of inter-unit HLA matching in double umbilical cord blood transplantation for acute leukemia
Published in Haematologica (Roma) (01-05-2017)“…The effects of inter-unit HLA-match on early outcomes with regards to double cord blood transplantation have not been established. Therefore, we studied the…”
Get full text
Journal Article -
19
A Phase I/Ib Study of Nivolumab for Relapsed Hematologic Malignancies after Allogeneic Hematopoietic Cell Transplantation (alloHCT)
Published in Blood (29-11-2018)“…Patients (pts) with relapsed hematologic malignancies (HM) after alloHCT are a unique population, given the potential to harness a dormant graft-vs.-tumor…”
Get full text
Journal Article -
20
HLA-haploidentical vs matched-sibling hematopoietic cell transplantation: a systematic review and meta-analysis
Published in Blood advances (10-09-2019)“…HLA haploidentical hematopoietic cell transplantation (haplo-HCT) using posttransplantation cyclophosphamide (PT-Cy) is an alternative strategy when a matched…”
Get full text
Journal Article